|
Welcome To Taj Pharmaceuticals Ltd API |
About Worldwide | FAQs | Careers | | Media Center | | Taj Pharmaceuticals World | | TAJ Group |
|||||
 |
|
|||||
 India
Latin
America/ Caribbean
Africa
& Middle East Asia
Russia Europe |
||||||
|
||||||
|
 Quetiapine Fumarate CAS number 111974-69-7  Systematic (IUPAC) name 2-(2-(4-dibenzo[b,f][1,4]thiazepine- 11-yl-1-piperazinyl)ethoxy)ethanol Identifiers CAS number 111974-69-7 ATC code N05AH04 PubChem 5002 DrugBank APRD00675 ChemSpider 4827 Chemical data Formula C21H25N3O2S Mol. mass 383.5099 g/mol SMILES eMolecules & PubChem Pharmacokinetic data Bioavailability 9% Metabolism Hepatic Half life 6 hours Excretion Renal Quetiapine is indicated for the treatment of schizophrenia, depressive episodes associated with bipolar disorder, acute manic episodes associated with bipolar I disorder (as either monotherapy or adjunct therapy to lithium or divalproex), and maintenance treatment of bipolar I disorder (as adjunct therapy to lithium or divalproex). It is sometimes used off-label, often as an augmentation agent, to treat such conditions as obsessive-compulsive disorder, post-traumatic stress disorder, restless legs syndrome, autism, alcoholism Tourette syndromeand has been used by physicians as a sedative for those with sleep disorders or anxiety disorders
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| More Api at Taj Pharmaceuticals Ltd. |
| Rabeprazole Sodium |
| Ramipril |
| Ranitidine Hydrochloride |
| Risperidone |
| Voriconazole |
| Primidone |
| Investor Relations Feedback Contact Worldwide Sitemap | |
©
2004 - 2009 Taj
Pharmaceuticals Limited .
All rights reserved
